Zilurgisertib New
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 2173389-57-4 | Cat. No. | BCP49234 |
| Name | Zilurgisertib | ||
| Synonyms | INCB-000928; NBU-928;INCB000928; NBU928;INCB 000928; NBU 928; | ||
| SMILES | C1COCCC1N2CC3CC3(C2)C4=CC=C(C=C4)C5=CC(=C(N=C5)N)C(=O)NC67CCC(CC6)(CC7)O | ||
| Chemical Name | |||
| Formula | C30H38N4O3 | M. Wt | 502.65 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Zilurgisertib is an inhibitor of activin A receptor type 1 (activin receptor-like kinase 2; ALK2; ALK-2; ACVR1; ACTR-I), with potential anti-anemic and ossification suppressive activities. Upon administration, zilurgisertib targets, binds to and inhibits the activity of ALK-2. This prevents ALK2-mediated signaling and ALK2-mediated excessive bone morphogenetic protein (BMP) signaling. This may suppress heterotopic ossification (HO). As ALK-2 enhances the secretion of hepcidin, a peptide liver hormone and a key modulator of iron homeostasis, zilurgisertib is able to decrease hepcidin expression in the liver, thereby increasing and restoring plasma iron levels, enhancing erythropoiesis, and correcting anemia of chronic disease (ACD). ALK2, a serine/threonine receptor kinase and type I cell surface receptor for BMPs, is constitutively activated due to activating mutations in inflammatory conditions, various types of cancer, and in fibrodysplasia ossificans progressiva (FOP). Elevated serum hepcidin levels enhance storage of iron, reduce iron availability and causes iron deficiency anemia. | ||
Recommend Products
More >
-
-
Zilurgisertib fumarate dihydrate
Cat. No.：BCP49233
No.：2173390-29-7
Product Details -
Disitertide
Cat. No.：BCP46789
No.：272105-42-7
Product Details -
TGFβRI-IN-3
Cat. No.：BCP46788
No.：2763602-67-9
Product Details -
TGFβRI-IN-3
Cat. No.：BCP46471
No.：TGFβRI-IN-3
Product Details -
-
SRI-011381 hydrochloride
Cat. No.：BCP44527
No.：2070014-88-7
Product Details -
-
-
-
(+)-ITD-1
Cat. No.：BCP29917
No.：1409968-46-2
Product Details -
Halofuginone Hydrobromide
Cat. No.：BCP19376
No.：64924-67-0
Product Details -
Halofuginone Hydrochloride
Cat. No.：BCP19375
No.：1217623-74-9
Product Details -
Halofuginone hydrobromide
Cat. No.：BCP24882
No.：17395-31-2
Product Details -
-
Halofuginone lactate
Cat. No.：BCP18878
No.：82186-71-8
Product Details -
Chebulinic acid
Cat. No.：BCP09990
No.：18942-26-2
Product Details -
-
Pirfenidone
Cat. No.：BCP04473
No.：53179-13-8
Product Details -
Halofuginone
Cat. No.：BCP07016
No.：55837-20-2
Product Details
Tags:Zilurgisertib supplier,Zilurgisertib purchase,Zilurgisertib manufacturer,Zilurgisertib distributor,Zilurgisertib cost,Zilurgisertib buy,Zilurgisertib for sale